Annals of the Rheumatic Diseases, 81(6):221733, 768-779. BMJ Publishing Group Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G J, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, ' EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome ', Annals of the Rheumatic Diseases, vol. 81, no. 6, pp. 768-779 . https://doi.org/10.1136/annrheumdis-2021-221733 Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S R, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A-K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G J, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, ' EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome ', Annals of the Rheumatic Diseases, vol. 81, no. 6, 221733, pp. 768-779 . https://doi.org/10.1136/annrheumdis-2021-221733